
Extended Half-Life (EHL) Factor Therapy
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options
Year: 2018
Language: English
Author(s): Elizabeth Duncan
Format: Video
In the Tuesday afternoon session entitled Role of Chromogenic Assays in Hemophilia Diagnosis, Elizabeth Duncan presented a comparison of clotting assays versus the chromogenic assay in quantifying FVIII, highlighting genotype and phenotype discrepancies and reverse discrepancies.

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options

This video gives a quick introduction to bispecific antibody therapy. Learn more about different treatment options for hemophilia with the

This video gives a quick introduction to standard half-life (SHL) clotting factor replacement therapy. Learn more about different treatment options

This fact sheet contains commonly asked questions and more information on standard half-life (SHL) and extended half-life (EHL) clotting factor

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The previous edition is also available in: Japanese The previous edition of this resource has also been translated into the